Does Kanna Work? Sorting Evidence From Hype

Wellness trends come and go, but every once in a while, something surfaces that has genuinely earned its reputation long before the marketing world discovered it. Kanna (Sceletium tortuosum) is one of those things.

Indigenous South African communities relied on it for centuries as a mood stabilizer, a social tonic, and a remedy for the mental strain of long hunts and hard days. 

Today it's showing up in supplements, beverages, and wellness circles worldwide, and the questions are coming with it. Does kanna work? Or is it just the latest trend riding a wave of clever branding?

The honest answer is: the science is real, the history is deep, and the nuance matters. This article pulls apart the evidence from the hype, explains what this plant does inside the brain, and walks through what current research supports. If you've been curious and want a grounded, no-nonsense take, this guide is for you.

Kamello combines kanna and noble kava in a ready-to-drink can designed for modern life. If you've been curious and want a grounded, no-nonsense take, this guide is for you.

Ancient Succulent, Modern Curiosity: Meet Kanna

Centuries of Use Before the Wellness World Arrived

Kanna is a small succulent native to the arid Karoo region of South Africa, where it has been used by the San and Khoikhoi peoples for generations as a traditional medicine and social tool. Historically, it was chewed, fermented, brewed into tea, or used as snuff to relieve fatigue, manage stress, and facilitate connection during communal gatherings.

The earliest recorded colonial documentation of its use dates to 1662, though its history with indigenous communities extends far beyond written records. What sets it apart from newer adaptogens is the depth of that ethnobotanical record.

This plant wasn't discovered by a wellness brand; it was already a sophisticated, multi-generational practice when European settlers first documented it. The scientific community is now catching up to what those communities already understood.

At Kamello, kanna is one of two key botanicals in each can, alongside noble kava, formulated to bring that same tradition of calm and connection into a modern ready-to-drink format.

Fermentation, Alkaloids, and Why Preparation Changes Everything

Traditional preparation involved fermenting the harvested plant material, a process known as kougoed that meaningfully alters the alkaloid profile. Fermentation converts a portion of mesembrine into mesembrenone, shifting the ratio toward a compound associated with a more anxiolytic and less stimulating experience.

The primary bioactive alkaloids in Sceletium tortuosum include mesembrine, mesembrenone, mesembrenol, and mesembranol. Their concentration and ratio vary depending on growing conditions, harvest timing, and preparation method.

This variability is one reason why experiences differ between products, and why standardized extracts have become important in research contexts.

Inside the Brain: What Kanna Does to Your Nervous System

Two Pathways, One Botanical

The question of whether kanna works is really a question about mechanism. 

Research identifies mesembrine alkaloids as functioning through two complementary pathways: serotonin reuptake inhibition (SRI) and phosphodiesterase-4 (PDE4) inhibition. In plain language, these alkaloids support serotonin availability in the brain while also modulating a signaling enzyme linked to mood and cognition.

Crucially, mesembrine functions as a natural, reversible inhibitor of the serotonin transporter (SERT), which distinguishes it from synthetic pharmaceutical SSRIs. Rather than forcing serotonin accumulation through irreversible binding, it works more gently within the same pathway.

This dual-action profile provides a plausible pharmacological explanation for the mood-lifting, anxiety-reducing effects that traditional users described long before neuroscience existed to explain them.

What Brain Scans Revealed That Self-Reports Couldn't

One of the more compelling pieces of evidence comes not from self-reported mood surveys, but from functional MRI. 

In a double-blind, placebo-controlled study published in Neuropsychopharmacology, researchers found that a single 25 mg dose of standardized Sceletium tortuosum extract measurably reduced reactivity in the amygdala, the brain region central to fear and threat processing.

The same study found reduced coupling between the amygdala and hypothalamus, a connectivity change consistent with a dampened stress response. This imaging evidence is particularly significant because it moves beyond subjective reports.

The brain was measurably responding in a way that aligned with the plant's traditional reputation for calming emotional reactivity. It doesn't prove kanna cures anxiety, but it demonstrates a real neurological signal worth taking seriously.

The Clinical Trials: Small Studies, Real Signals

Sharper Thinking, Better Sleep, More Ease

The most extensively studied kanna extract in clinical research is Zembrin, a standardized formulation used across several placebo-controlled trials. I

n a randomized controlled trial of 21 cognitively healthy adults between 45 and 65 years old, participants taking 25 mg of Zembrin daily for three weeks showed statistically significant improvements in cognitive flexibility and executive function compared to placebo. The same group also reported improvements in sleep quality and sleep onset.

These cognitive benefits are mechanistically connected to kanna's PDE4 inhibition. PDE4 regulates cyclic AMP (cAMP) signaling, a pathway tied to memory consolidation and neuroprotection. Inhibiting PDE4 prolongs the cAMP signal, which may help explain why cognitive improvements appeared in trials even at modest doses.

A separate trial of 60 physically active adults aged 20 to 35 found that eight days of Zembrin supplementation significantly improved complex reactive performance compared to placebo, a cognitively demanding task requiring rapid visual processing and decision-making.

Anxiety: What the Research Gets Right and Where It Falls Short

A 2020 placebo-controlled study testing a single 25 mg dose of Zembrin in healthy volunteers found that participants reported significantly lower subjective anxiety during a simulated public speaking task compared to those given a placebo. 

A separate six-week clinical trial using a 50 mg daily dose found a significant reduction in scores on the Hamilton Anxiety Rating Scale (HAMA-A), a validated clinical instrument for measuring anxiety severity.

That said, a fair reading of the research also acknowledges its limits. Trial sample sizes have generally been small, and a meta-analysis examining pooled anxiety outcomes across four randomized clinical trials found no statistically significant difference between kanna and placebo on formal anxiety measures.

The evidence is directionally positive and mechanistically supported, but the field still needs larger, longer trials to draw firm conclusions about anxiety specifically.

Separating Signal From Noise: The Claims Worth Questioning

What Kanna Is Not (And Was Never Meant to Be)

With any botanical that gains mainstream momentum, exaggerated claims tend to follow. Sceletium tortuosum is sometimes marketed with language that implies it functions like a recreational stimulant or a substitute for pharmaceutical interventions. Neither is accurate.

It is not classified as a narcotic and is considered a relatively mild, non-addictive substance when used appropriately. It does not produce hallucinations, and its psychoactive range is subtle rather than dramatic.

One reason it carries lower addiction risk is that its alkaloids do not act on dopamine reward pathways in the way that substances with abuse potential typically do. Its serotonergic action is reversible and mild, a meaningful distinction from both pharmaceutical SSRIs and recreational drugs that work on the dopaminergic system.

It is also not a replacement for clinical mental health treatment, and the existing research reflects effects in generally healthy adults at studied doses.

Why Sourcing and Standardization Make or Break the Experience

One of the most overlooked variables in this conversation is product quality. 

Because the alkaloid composition varies naturally with growing conditions and preparation, products using non-standardized or poorly sourced plant material may behave very differently from the extracts studied in clinical settings.

It's also worth noting that most commercial products, including beverage formats, are not Zembrin specifically. Clinical findings on that extract are informative about what kanna's alkaloids can do, but they don't automatically transfer to every product on the market.

This is why formulation transparency matters. At Kamello, each 12 fl oz can contains 50 mg of kanna extract alongside 50 mg of kavalactones from kava root extract, with full supplement facts published on the product page.

The Bigger Picture: A Botanical Finding Its Scientific Footing

A Short Research Timeline for a Very Old Plant

Kanna's modern research timeline is notably short given its millennia of traditional use. The first rigorous clinical trials using standardized extract were conducted between 2013 and 2017, which means the peer-reviewed literature is still in early stages.

Current evidence supports plausible mechanisms, measurable neurological effects, and modest cognitive benefits. Long-term safety data from controlled trials is still limited, though studies conducted to date report that Zembrin was well tolerated, with adverse event rates comparable to or lower than placebo.

This trajectory is not unusual for ethnobotanicals navigating the path from traditional use to clinical validation. Kava itself went through decades of research before finding mainstream acceptance. Sceletium tortuosum is on a similar path, with a growing body of peer-reviewed work behind it and more underway.

Kava and Kanna Together: Why the Pairing Makes Functional Sense

At Kamello, kanna is formulated alongside kava because their effects are complementary rather than redundant. 

Kava's kavalactones work primarily through GABA pathways, promoting physical relaxation and easing social tension. Kanna's mesembrine alkaloids support mood elevation and cognitive ease through serotonergic and PDE4 pathways.

The two botanicals address different dimensions of stress and social inhibition. It's also worth noting that liquid delivery formats allow alkaloids to be absorbed through the gastrointestinal tract without the dissolution step required by capsules, which may support a more efficient onset compared to solid-dose formats.

Ready to Experience the Evidence Yourself?

The research on kanna points in a consistent direction: a real botanical with a documented mechanism, early but credible clinical evidence, and a safety profile that compares favorably to many alternatives. 

It isn't magic, and the science still has room to grow. But for anyone seeking calm, mental ease, and a more connected social experience without alcohol or pharmaceuticals, kanna is one of the more substantiated options available.

Kamello brings kanna and kava together in a single, thoughtfully formulated ready-to-drink can. Three distinct flavors, Citrus Blossom, Peach and Black Tea, and Spiced Coffee, each containing 50 mg of kanna extract per serving. 

Explore the full Kamello collection today and find the ritual that fits your life.

Frequently Asked Questions

Can kanna be taken daily, or is it better used occasionally?

Kanna has been studied in both daily-use and short-term contexts, but “studied daily” does not mean daily use is necessary or appropriate for everyone. In a randomized, double-blind, placebo-controlled safety trial, standardized Sceletium tortuosum extract was used once daily for three months in healthy adults and was reported to be well tolerated at the studied doses.

Other human studies have used daily dosing for shorter periods. For example, a small randomized crossover study in adults ages 45 to 65 evaluated 25 mg per day of standardized Sceletium extract and reported findings related to cognitive flexibility, executive function, and tolerability. 

These studies are useful because they show that controlled daily use has been formally tested, but they do not prove that daily use is the best approach for every person, every product, or every wellness goal.

For practical use, occasional kanna may make more sense for people who want situational support for social ease, relaxation, or stressful moments, while daily use should be approached more thoughtfully. The current research base is still small, and a peer-reviewed review of Sceletium research in Molecules notes that human evidence remains early and product-specific.

A cautious approach is to start with the lowest suggested serving, avoid stacking several mood-active products at once, and reassess how you feel over time. 

Anyone taking prescription medications, managing a mood disorder, preparing for surgery, pregnant, breastfeeding, or using multiple supplements should ask a healthcare professional first, since NCCIH explains that dietary supplements can interact with medications or pose risks in certain health situations in its guide to using dietary supplements wisely.

Is kanna regulated by the FDA?

In the United States, kanna products sold as supplements are generally regulated as dietary supplements, not as prescription drugs. That distinction matters because dietary supplements do not go through the same premarket approval process for safety and effectiveness that drugs do. 

The FDA explains that supplement companies may make certain structure/function claims, but they cannot legally claim that a supplement diagnoses, treats, cures, or prevents disease, as outlined in the FDA’s page on structure/function claims.

That means a kanna product can be marketed with general wellness language, but it should not be marketed as a treatment for anxiety, depression, insomnia, ADHD, or any other medical condition unless it has gone through the drug approval process for that use. 

The FDA also explains that companies making certain dietary supplement labeling claims must notify the agency after marketing the product, but that notification is not the same thing as FDA approval, as described in the FDA guidance on structure/function and related claim notifications.

For consumers, the most useful takeaway is to evaluate the product, not just the ingredient. Look for a clear Supplement Facts panel, the amount of kanna extract per serving, other active ingredients, serving instructions, safety warnings, and realistic language that avoids disease-treatment promises. 

NCCIH notes that supplements sold in stores or online can differ in important ways from the products tested in research studies, which is especially relevant for botanicals like kanna where extract type and alkaloid profile may vary, as explained in its overview of dietary and herbal supplements.

Full labeling transparency is an important starting point, but it is not a guarantee that a product will affect every person the same way or match the exact extract used in clinical trials. 

The most scientifically defensible position is that FDA rules provide a regulatory framework for supplement labeling and safety enforcement, while consumers still need to pay attention to product quality, serving size, medication interactions, and the strength of the evidence behind specific claims.

Does kanna interact with common supplements like magnesium or ashwagandha?

There is not enough clinical research to say that kanna has a well-established interaction with common supplements like magnesium, ashwagandha, or L-theanine. However, that does not mean every combination is automatically risk-free. 

The safer interpretation is that interaction data are limited, and combining multiple calming, sedating, or mood-active products can make it harder to predict how you will feel.

Magnesium is an essential mineral involved in nerve and muscle function, blood glucose control, and blood pressure regulation, according to the NIH Office of Dietary Supplements magnesium fact sheet. 

It is not generally discussed as a serotonergic supplement in the same way kanna is, but magnesium supplements can still cause side effects at higher supplemental intakes and may interact with some medications, including certain antibiotics and bisphosphonates.

Ashwagandha deserves more caution because it is also used for stress and relaxation, and NCCIH notes that it can cause drowsiness, stomach upset, diarrhea, and vomiting in some people. 

NCCIH also states that rare cases have linked ashwagandha supplements to liver injury and that ashwagandha should be avoided during pregnancy and not used while breastfeeding, according to its safety overview of ashwagandha.

The main concern with stacking kanna is not that every combination is proven dangerous. The concern is that overlapping effects can add up, especially if a person is also using alcohol, sedatives, antidepressants, sleep aids, or other supplements that affect mood, alertness, or liver metabolism. 

The FDA cautions that dietary supplements can interact with medications in unexpected ways in its consumer update on mixing medications and dietary supplements, so people using several wellness products at once should discuss the full list with a clinician or pharmacist.

How does kanna differ from kratom?

Kanna and kratom are both botanicals, but they are not interchangeable. 

Kanna comes from Sceletium tortuosum and is mainly studied for alkaloids such as mesembrine and mesembrenone, with research identifying activity at the serotonin transporter and phosphodiesterase-4, or PDE4, as described in this PubMed-indexed pharmacology study. 

That helps explain why kanna is usually discussed in relation to mood, stress, and cognitive flexibility rather than pain relief or opioid-like effects.

Kratom comes from Mitragyna speciosa and is discussed very differently by public health agencies. The FDA warns consumers not to use kratom because of risks that include liver toxicity, seizures, substance use disorder, and serious adverse events, according to the agency’s public health page on FDA and kratom. 

The FDA also states that there are no FDA-approved kratom drug products or legally marketed over-the-counter kratom drug products in the United States.

The mechanism distinction is important. FDA materials describe 7-hydroxymitragynine, a kratom-related compound, as having opioid receptor activity and potential for abuse, as discussed in the FDA announcement on 7-OH opioid products. 

Kanna’s available pharmacology research points instead to serotonin transporter and PDE4 activity, which places it in a different scientific and safety category.

That does not mean kanna should be described as risk-free. The better comparison is that kratom carries specific FDA-identified concerns related to opioid-like effects and serious adverse events, while kanna has a smaller and more preliminary human evidence base focused on standardized extracts, mood-related mechanisms, and tolerability in healthy adults. 

Consumers should avoid treating either botanical as a casual substitute for medical care.

Can kanna affect alertness, driving, or alcohol use?

Kanna can be subtle, but subtle does not always mean irrelevant for safety. Because kanna is mood-active and may feel calming, uplifting, or relaxing depending on the person and product, it is wise not to drive, operate machinery, or perform safety-sensitive tasks the first time you use it. 

People vary in their response to botanicals, and NCCIH cautions that dietary supplements may interact with medications or pose risks in certain situations in its guide to using dietary supplements wisely. This caution is especially important when kanna is used in a beverage format or in social settings where alcohol may also be present. 

Alcohol is well known to impair judgment, coordination, reaction time, and driving ability, and the National Institute on Alcohol Abuse and Alcoholism explains that alcohol affects the brain and body in ways that can increase injury risk in its overview of alcohol’s effects on health.

There is also no widely accepted roadside test or legal impairment threshold for kanna comparable to blood alcohol concentration limits for alcohol. That means the safest practical standard is behavioral, not numerical. 

If you feel unusually relaxed, slowed, lightheaded, drowsy, emotionally altered, or less sharp than usual, do not drive or do anything that requires quick reaction time.

For Kamello specifically, consumers should also remember that the formula includes both kanna and kava, so the alertness question is not about kanna alone. Kava has its own relaxation profile, and combining relaxing botanicals with alcohol, sedatives, sleep aids, or other calming supplements may increase the chance of unwanted impairment. 

The FDA warns that supplements and medications can interact in ways that affect safety in its consumer update on mixing medications and dietary supplements, so the safest approach is to avoid alcohol mixing and wait to understand your individual response before driving.

Are there any populations who should avoid kanna?

Pregnant and breastfeeding individuals should avoid kanna unless a qualified healthcare professional specifically advises otherwise. This is not because kanna has been proven harmful in pregnancy or lactation, but because there is not enough human safety evidence in these groups. 

NCCIH notes that many dietary supplements have not been tested in pregnant people, nursing mothers, or children in its guide to using dietary supplements wisely.

People taking antidepressants or other serotonin-active medications should be especially cautious. Pharmacology research has found that Sceletium tortuosum extract can affect the serotonin transporter, as described in this PubMed-indexed study. 

FDA-approved labeling for escitalopram, a common SSRI, warns that SSRIs can contribute to serotonin syndrome, a potentially life-threatening condition, especially when used with other serotonergic substances, as shown in the FDA label for escitalopram capsules.

People with bipolar disorder, a history of mania or hypomania, seizure disorders, significant liver disease, complex medication regimens, or upcoming surgery should also ask a healthcare professional before using kanna. 

This is a precaution based on limited human interaction data and the general principle that botanicals with central nervous system activity deserve more care in medically complex situations. NCCIH specifically advises telling healthcare providers about all supplements and medications so they can help avoid harmful interactions in its guide on how medications and supplements can interact.

Children and adolescents should not use kanna unless directed by a healthcare professional. Most published human studies have focused on adults, often healthy adults, and that evidence should not be generalized to younger populations.